RosVivo Therapeutics targets diseases with breakthrough therapies utilizing microRNA (miRNA) and small interfering-RNA (siRNA) drugs. They're using unique scientific insights to develop a new pipeline of first-in-class drugs and diagnostic tests. Their development programs focus on the leading T2D, obesity, and COVID-19 drug candidates.

Biotechnology

RosVivo Therapeutics

RosVivo Therapeutics' headquarters in Reno, NV, United States

Junghak Kim

Sandra Poudrier

Seungil Ro

Linda Nguyen

Myung Suk Song

Richard On

Peter Kim

Takara Leah Stanley

Fadi Hendee

Kenton M. Sanders

Arthur Beyder

Description

People (1)

Kenton M. Sanders

Jobs